Funding for this research was provided by:
Breast Cancer Research Foundation (BCRF-17-194, BCRF-18-140)
National Cancer Institute (R01CA142942)
Received: 13 November 2020
Accepted: 19 January 2021
First Online: 30 January 2021
Ethics approval and consent to participate
: The study was retrospective, entailing use of routinely collected data and archival benign breast disease tissue. Hence, no verbal or written consent was obtained. All data were fully anonymized before access by the researchers, and the study was approved by the Committee on Clinical Investigations of the Albert Einstein College of Medicine and by the Kaiser Permanente Northwest Biospecimen Review Committee.
: All authors have given consent for publication.
: The authors declare that they have no competing interests.